Daxor Corporation (DXR) Stock Analysis

Daxor Corporation (DXR) is a publicly traded company in the HEALTHCARE sector. It trades at $10.62, carries a market capitalization of $58.62M, a price-to-earnings ratio of 6.13. This page summarizes the public market data, fundamentals, and frequently asked questions for DXR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Daxor Corporation currently has a Bullish sentiment score of 0.41.

About Daxor Corporation

Daxor Corporation (DXR) is a pioneering medical device company headquartered in New York, dedicated to revolutionizing patient care through advanced blood volume monitoring technology. Specializing in cryobank and biotechnology services, Daxor's innovative solutions are designed to transform blood management practices within healthcare facilities across the United States. With a strong emphasis on improving health outcomes, Daxor leverages its proprietary technologies and cutting-edge researc...

GNG Research Analysis

GNG Research scores Daxor Corporation (DXR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DXR.

Frequently Asked Questions

Does DXR pay dividends?

Daxor Corporation (DXR) does not currently pay a regular dividend.

What is DXR's P/E ratio?

Daxor Corporation has a price-to-earnings (P/E) ratio of 6.13.

What is DXR's market cap?

Daxor Corporation (DXR) has a market capitalization of $58.62M with a current stock price of $10.62.